Article citationsMore>>

R. Rosell, R. Gervais, A. Vergnenegre, et al., “Erlotinib versus Chemotherapy (CT) in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients (p) with Epidermal Growth Factor Receptor (EGFR) Mutations: Interim Results of the European Erlotinib versus Chemotherapy (EURTAC) Phase III Randomized Trial,” Journal of Clinical Oncology, Vol. 29, 2011, Abstract 7503.

has been cited by the following article: